Koers NexgenRx Inc. Toronto S.E.
Aandelen
NXG
CA65337X1042
Beleggingsbeheer & Fondsbeheerders
Omzet 2022 | 12,78 mln. 9,28 mln. 8,62 mln. | Omzet 2023 | 13,85 mln. 10,06 mln. 9,34 mln. | Marktkapitalisatie | 15,52 mln. 11,27 mln. 10,47 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 0 | Nettowinst (verlies) 2023 | - 0 0 | EV/omzet 2022 | 1,35 x |
Nettoliquiditeiten 2022 | 1,33 mln. 969K 900K | Nettoliquiditeiten 2023 | 1,41 mln. 1,03 mln. 954K | EV/omzet 2023 | 1,02 x |
K/w-verhouding 2022 |
-833
x | K/w-verhouding 2023 |
-46,7
x | Werknemers | - |
Dividendrendement 2022 |
3,77% | Dividendrendement 2023 |
4,55% | Vrij verhandelbaar | 63,15% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Loucks
FOU | Founder | - | 13-03-03 |
Director of Finance/CFO | 61 | 05-12-16 | |
Jason Robinson
ADM | Chief Administrative Officer | - | 01-01-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ronald Loucks
FOU | Founder | - | 13-03-03 |
Chairman | - | 07-03-06 | |
Charles Burns
BRD | Director/Board Member | - | 16-06-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,62% | 114 mld. | |
+7,39% | 102 mld. | |
+7,86% | 64,37 mld. | |
+27,45% | 63,93 mld. | |
+16,70% | 45,1 mld. | |
+12,81% | 42,37 mld. | |
+21,73% | 35,9 mld. | |
+6,85% | 25,8 mld. | |
-4,01% | 22,52 mld. |